Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjørn Naume

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2005
Circulating and disseminated tumor cellsStephan Braun, Bjørn Naume
Nature Clinical Practice. Oncology|February 10, 2007
Can detection of circulating tumor cells in peripheral blood provide prognostic data in breast cancer?Gro Wiedswang, Bjørn Naume
Plos One|March 3, 2012
A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patientsTimothy J Molloy, Paul Roepman, Bjørn Naume, et al.
Breast Cancer Research and Treatment|December 30, 2008
Kwan's arm problem scale: psychometric examination in a sample of stage II breast cancer survivorsInger-Lise Nesvold, Sophie D Fosså, Bjørn Naume, et al.
Breast Cancer Research and Treatment|February 17, 2009
The prognostic impact of occult nodal metastasis in early breast carcinomaDaehoon Park, Rolf Kåresen, Bjørn Naume, et al.
International Journal of Medical Informatics|March 28, 2019
Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registryOlaf Johan Hartmann-Johnsen, Rolf Kåresen, Ellen Schlichting, et al.
Acta Oncologica (Stockholm, Sweden)|October 22, 2009
Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of lifeInger-Lise Nesvold, Sophie D Fosså, Inger Holm, et al.
ISRN Oncology|June 6, 2012
Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical TrialOlav Engebraaten, Hege Edvardsen, Erik Løkkevik, et al.
BMC Cancer|July 16, 2014
Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patientsBjørnar Gilje, Oddmund Nordgård, Kjersti Tjensvoll, et al.
BMC Cancer|June 1, 2020
Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016Yngvar Nilssen, Odd Terje Brustugun, Morten Tandberg Eriksen, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2005
Circulating and disseminated tumor cellsStephan Braun, Bjørn Naume
Nature Clinical Practice. Oncology|February 10, 2007
Can detection of circulating tumor cells in peripheral blood provide prognostic data in breast cancer?Gro Wiedswang, Bjørn Naume
Plos One|March 3, 2012
A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patientsTimothy J Molloy, Paul Roepman, Bjørn Naume, et al.
Breast Cancer Research and Treatment|December 30, 2008
Kwan's arm problem scale: psychometric examination in a sample of stage II breast cancer survivorsInger-Lise Nesvold, Sophie D Fosså, Bjørn Naume, et al.
Breast Cancer Research and Treatment|February 17, 2009
The prognostic impact of occult nodal metastasis in early breast carcinomaDaehoon Park, Rolf Kåresen, Bjørn Naume, et al.
International Journal of Medical Informatics|March 28, 2019
Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registryOlaf Johan Hartmann-Johnsen, Rolf Kåresen, Ellen Schlichting, et al.
Acta Oncologica (Stockholm, Sweden)|October 22, 2009
Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of lifeInger-Lise Nesvold, Sophie D Fosså, Inger Holm, et al.
ISRN Oncology|June 6, 2012
Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical TrialOlav Engebraaten, Hege Edvardsen, Erik Løkkevik, et al.
BMC Cancer|July 16, 2014
Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patientsBjørnar Gilje, Oddmund Nordgård, Kjersti Tjensvoll, et al.
BMC Cancer|June 1, 2020
Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016Yngvar Nilssen, Odd Terje Brustugun, Morten Tandberg Eriksen, et al.
Pageof 11